Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

    Michele Bibas
    e2024015
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.015
    1772
    PDF: 1683
    HTML: 872
  • USP9X INCREASED TUMOR ANGIOGENESIS IN MANTLE CELL LYMPHOMA BY UPREGULATION OF CCND1- MEDIATED SOX11

    Gang Huang, Jianjun Liao, Mingli Wang, Yali Huang, Mingjie Tang, Yanyan Hao
    e2022048
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.048
    842
    PDF: 701
    HTML: 213
  • CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2022069
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.069
    3017
    PDF: 907
    HTML: 1983
  • THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.

    Francesco Maura, Lucia Farina, Paolo Corradini
    e2016045
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.045
    4060
    PDF: 1154
    HTML: 1945
    Fig.1: 219
    Fig. 2: 112
    Table 1: 204
    Table2: 220
    Table 3: 200
  • SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW

    Francesca Pavanello, Sara Steffanoni, Michele Ghielmini, Emanuele Zucca
    e2016062
    2016-11-06
    https://doi.org/10.4084/mjhid.2016.062
    3766
    PDF: 1068
    HTML: 2055
  • CIRCCTNNA1 IS UPREGULATED IN MANTLE CELL LYMPHOMA AND PREDICTS POOR SURVIVAL BY SPONGING MIR-34A TO INCREASE CELL PROLIFERATION.

    Xuebing Jing, Cong Lu, Chao Song, Qingkun Han
    e2022047
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.047
    659
    PDF: 523
    HTML: 224
  • FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT

    Alessia Castellino, Umberto Vitolo
    e2017009
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.009
    4439
    PDF: 1644
    HTML: 3819
    Tables and Images: 223
  • TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo
    e2025039
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.039
    2254
    PDF: 1518
    HTML: 269
  • INTEGRATION OF CD200, CD43 AND ROR1 IN MULTIPARAMETER FLOW CYTOMETRY (MFC) ROUTINE PANELS FOR THE DIFFERENTIAL DIAGNOSIS OF B-CELL LYMPHOPROLIFERATIVE DISORDERS (B-LPDS)

    Alessandro Laganà, Raffaele Maglione, Alessandro Costa, Biancamaria Mandelli, Maria Laura Bisegna, Maria Laura Milani, Valeria Filipponi, Maria Grazia Nardacci, Tania Soriano, Eugenio Santacroce, Luigi Petrucci, Carla Giordano, Maurizio Martelli, Maria Stefania De Propris
    e2025.002
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.002
    2336
    PDF: 1505
    HTML: 363
    PDF: 1023
  • Skin Manifestations associated with Mantle cell Lymphoma: a case report

    avinash kumar singh, Gaurav Dixit, sanjeev sharma, rajni yadav, Narendra agrawaal, chitra sarkar, pravas mishra, Tulika seth, manoranjan mahapatra, Renu saxena
    e2013020
    2013-02-24
    https://doi.org/10.4084/mjhid.2013.020
    1560
    PDF: 766
    HTML: 2142
    Untitled: 224
    Untitled: 197
    Untitled: 194
    Untitled: 203
    Untitled: 199
  • NOVEL DRUGS IN FOLLICULAR LYMPHOMA

    Giuseppe Rossi, Antonella Anastasia
    e2016061
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.061
    4335
    PDF: 1493
    HTML: 1552
    Untitled: 233
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS

    Michele Bibas, Shayna Sarosiek, Jorge J. Castillo
    e2024061
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.061
    2793
    PDF: 3227
    HTML: 505
  • FLUDARABINE-MELPHALAN-CAMPATH FOLLOWED BY UNMANIPULATED PERIPHERAL-BLOOD HAEMATOPOIETIC STEM CELLS CAN STILL CURE LYMPHOMA.

    Daniele Avenoso, Amal Alabdulwahab, Michelle Kenyon, Varun Mehra, Pramila Krishnamurthy, Francesco Dazzi, Ye Ting Leung, Sandra Anteh, Mili Naresh Shah, Andrea Kuhnl, Robin Sanderson, Piers Patten, Deborah Yallop, Antonio Pagliuca, Victoria Potter
    e2023041
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.041
    1610
    PDF: 720
    HTML: 220
  • Severe CMV infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in an old mantle cell lymphoma patient

    Gabriele Magliano, Annarosa Cuccaro, Francesco D'Alo', Elena Maiolo, Silvia Bellesi, Stefan Hohaus, Andrea Bacigalupo, Livio Pagano
    e2021054
    2021-08-28
    https://doi.org/10.4084/MJHID.2021.054
    1229
    PDF: 401
    HTML: 162
  • Mantle cell lymphoma relapsing at the lymphedematous arm.

    Giuseppina Massini, Stefan Hohaus, Francesco D'Alo', Valentina Bozzoli, Barbara Vannata, Luigi Maria Larocca, Luciana Teofili
    e2013016
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.016
    1707
    PDF: 697
    HTML: 3800
  • IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS

    Efterpi Kostareli, Maria Gounari, Andreas Agathangelidis, Kostas Stamatopoulos
    e2012052
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.052
    3076
    PDF: 881
    HTML: 7168
    Kost Fig1: 186
    Kost Fig 2: 181
    Kost Fig3: 180
    Kost Fig 4: 194
    Kost Fig5: 187
    Kost fig 6: 176
  • INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH CHRONIC LYMPHOPROLIFERATIVE DISORDERS IN THE ERA OF TARGET DRUGS

    Livio Pagano, Davide Facchinelli, Dr.
    e2018063
    2018-10-27
    https://doi.org/10.4084/mjhid.2018.063
    2058
    PDF: 1120
    HTML: 223
1 - 17 of 17 items
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy